Literature DB >> 1610980

Effects of insulin and glucose on renal phosphate reabsorption: interactions with dietary phosphate.

M Allon1.   

Abstract

Both insulin deficiency and glycosuria are known to inhibit the tubular reabsorption of phosphate. This inhibition has previously been evaluated either in the fasted state or on a normal phosphate diet. The goal of this study was to evaluate how dietary phosphate depletion affected the relative effects of insulin deficiency and glycosuria on the tubular reabsorption of phosphate. Rats were maintained on either a low- (0.03%) or normal (0.8%) phosphate diet. After 5 days, one half of the animals in each group received streptozotocin to induce short-term insulin deficiency, whereas the other half received vehicle alone. Two days later, sodium-dependent phosphate uptake by renal brush border membrane vesicles (BBMV) was evaluated in each of the four experimental groups. The effect of glucose on phosphate uptake was determined by the addition of varying concentrations of glucose (between 0 and 32 mmol/L) to the extravesicular transport fluid. BBMV phosphate uptake was about threefold higher in the nondiabetic rats fed a low-phosphate diet as compared with the nondiabetic animals maintained on a normal phosphate diet. In rats maintained on a low-phosphate diet, streptozotocin treatment prevented the increase in BBMV phosphate transport; in contrast, in animals fed a normal phosphate diet, streptozotocin treatment had no effect on BBMV phosphate transport. Extravesicular glucose significantly inhibited phosphate transport in a dose-related manner, regardless of dietary phosphate or insulin status. Because fasting mimics the catabolic state associated with insulin deficiency, BBMV phosphate transport was also measured in rats fasted for 48 h after the administration of streptozotocin or vehicle.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1610980     DOI: 10.1681/ASN.V2111593

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  6 in total

1.  PKB/SGK-resistant GSK3 enhances phosphaturia and calciuria.

Authors:  Michael Föller; Daniela S Kempe; Krishna M Boini; Ganesh Pathare; Balasaheb Siraskar; Paola Capuano; Ioana Alesutan; Mentor Sopjani; Gerti Stange; Nilufar Mohebbi; Madhuri Bhandaru; Teresa F Ackermann; Martin S Judenhofer; Bernd J Pichler; Jürg Biber; Carsten A Wagner; Florian Lang
Journal:  J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 10.121

2.  Upregulation of the Na⁺-coupled phosphate cotransporters NaPi-IIa and NaPi-IIb by B-RAF.

Authors:  Tatsiana Pakladok; Zohreh Hosseinzadeh; Aleksandra Lebedeva; Ioana Alesutan; Florian Lang
Journal:  J Membr Biol       Date:  2013-11-21       Impact factor: 1.843

3.  Decreased bone density and increased phosphaturia in gene-targeted mice lacking functional serum- and glucocorticoid-inducible kinase 3.

Authors:  Madhuri Bhandaru; Daniela S Kempe; Anand Rotte; Paola Capuano; Ganesh Pathare; Mentor Sopjani; Ioana Alesutan; Leonid Tyan; Dan Yang Huang; Balasaheb Siraskar; Martin S Judenhofer; Gerti Stange; Bernd J Pichler; Jürg Biber; Leticia Quintanilla-Martinez; Carsten A Wagner; David Pearce; Michael Föller; Florian Lang
Journal:  Kidney Int       Date:  2011-03-30       Impact factor: 10.612

4.  Incidence and determinants of hypophosphatemia in diabetic ketoacidosis: an observational study.

Authors:  Amarens van der Vaart; Femke Waanders; André P van Beek; Titia M Vriesendorp; B H R Wolffenbutel; Peter R van Dijk
Journal:  BMJ Open Diabetes Res Care       Date:  2021-02

5.  PHEX mimetic (SPR4-peptide) corrects and improves HYP and wild type mice energy-metabolism.

Authors:  Lesya V Zelenchuk; Anne-Marie Hedge; Peter S N Rowe
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

6.  Phosphate and fibroblast growth factor 23 in diabetes.

Authors:  Amarens van der Vaart; Stanley M H Yeung; Peter R van Dijk; Stephan J L Bakker; Martin H de Borst
Journal:  Clin Sci (Lond)       Date:  2021-07-30       Impact factor: 6.124

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.